Activin a is associated with impaired myocardial glucose metabolism and left ventricular remodeling in patients with uncomplicated type 2 diabetes

Activin-A in Diabetes-Induced Cardiac Malformations in Embryos

(2013) Zhiyong Zhao   BIRTH DEFECTS RESEARCH PART B-DEVELOPMENTAL AND REPRODUCTIVE TOXICOLOGY

Interleukin-6 and activin A are independently associated with cardiovascular events and mortality in type 2 diabetes: the prospective Asker and Bærum Cardiovascular Diabetes (ABCD) cohort study

(2013) Anne Ofstad et al.   Cardiovascular Diabetology

Myocardial dysfunction in patients with type 2 diabetes mellitus: role of endothelial progenitor cells and oxidative stress

(2012) Chun Zhao et al.   Cardiovascular Diabetology

Increased myocardial SERCA expression in early type 2 diabetes mellitus is insulin dependent: In vivo and in vitro data

(2012) Sabine Fredersdorf et al.   Cardiovascular Diabetology

Secretory Products From Epicardial Adipose Tissue of Patients With Type 2 Diabetes Mellitus Induce Cardiomyocyte Dysfunction

(2012) Sabrina Greulich et al.   CIRCULATION

Activin A and cardiovascular disease in type 2 diabetes mellitus

(2012) Thor Ueland et al.   Diabetes & Vascular Disease Research

Association of plasma osteoprotegerin and adiponectin with arterial function, cardiac function and metabolism in asymptomatic type 2 diabetic men

(2011) Weena JY Chen et al.   Cardiovascular Diabetology

Activin A Levels Are Associated With Abnormal Glucose Regulation in Patients With Myocardial Infarction: Potential Counteracting Effects of Activin A on Inflammation

(2011) G. O. Andersen et al.   DIABETES

Activin A Plays a Critical Role in Proliferation and Differentiation of Human Adipose Progenitors

(2010) L.-E. Zaragosi et al.   DIABETES

The role of epicardial and perivascular adipose tissue in the pathophysiology of cardiovascular disease

(2010) D. Margriet Ouwens et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

A Complex Role of Activin A in Non-Alcoholic Fatty Liver Disease

(2009) Arne Yndestad et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Pioglitazone Improves Cardiac Function and Alters Myocardial Substrate Metabolism Without Affecting Cardiac Triglyceride Accumulation and High-Energy Phosphate Metabolism in Patients With Well-Controlled Type 2 Diabetes Mellitus

(2009) Rutger W. van der Meer et al.   CIRCULATION

Adiponectin upregulates monocytic activin A but systemic levels are not altered in obesity or type 2 diabetes

(2009) Johanna Weigert et al.   CYTOKINE

Altered Myocardial Substrate Metabolism and Decreased Diastolic Function in Nonischemic Human Diabetic Cardiomyopathy

(2009) Luuk J. Rijzewijk et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Myocardial Steatosis Is an Independent Predictor of Diastolic Dysfunction in Type 2 Diabetes Mellitus

(2008) Luuk J. Rijzewijk et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY